Table 2.
Baseline characteristics of the CSF group and NCSF group.
| Variable | NCSF (n=294) | CSF(n=435) | p-value |
|---|---|---|---|
| Male sex, n (%) | 118 (40.1) | 277 (63.7) | <0.001 |
| Hypertension, n (%) | 163 (54.5) | 213 (49.0) | 0.086 |
| Diabetes, n (%) | 52 (17.7) | 80 (18.4) | 0.809 |
| Hyperlipidemia, n (%) | 45 (15.3) | 63 (14.5) | 0.759 |
| Smoking history, n (%) | 81 (27.6) | 181 (41.6) | <0.001 |
| Alcohol consumption, n (%) | 76 (25.9) | 181 (41.6) | <0.001 |
| Age (year) | 58 ± 11 | 56 ± 10 | 0.041 |
| Heart rate (bpm) | 77 ± 11 | 76 ± 12 | 0.115 |
| SBP (mmHg) | 131 ± 18 | 131 ± 16 | 0.266 |
| DBP (mmHg) | 75 ± 11 | 77 ± 11 | 0.022 |
| Height (cm) | 164.4 ± 7.6 | 168.2 ± 8.1 | <0.001 |
| Weight (kg) | 69.5 ± 12.9 | 75.4 ± 13.5 | <0.001 |
| BMI (kg/m2) | 25.63 ± 3.80 | 26.54 ± 3.64 | 0.001 |
| LVEDD (mm) | 44.09 ± 3.81 | 45.03 ± 3.91 | 0.001 |
| LVESD (mm) | 29.50 ± 3.08 | 30.10 ± 3.21 | 0.011 |
| EF (%) | 61.67 ± 4.62 | 61.54 ± 4.97 | 0.724 |
| IVSd (mm) | 10.49 ± 1.17 | 10.77 ± 1.17 | 0.001 |
| LA-ap (mm) | 33.84 ± 3.81 | 34.64 ± 4.01 | 0.007 |
| Mitral valve E peak velocity (m/s) | 0.67 ± 0.16 | 0.64 ± 0.16 | 0.004 |
| Mitral valve A peak velocity (m/s) | 0.79 ± 0.16 | 0.76 ± 0.17 | 0.009 |
| AV-v (m/s) | 1.32 ± 0.24 | 1.30 ± 0.24 | 0.254 |
| Mitral valve E/A ratio | 0.88 ± 0.26 | 0.88 ± 0.29 | 0.953 |
| LVM (g) | 227.3 ± 46.6 | 242.3 ± 48.9 | <0.001 |
| Urea (mmol/l) | 5.21 ± 1.44 | 5.38 ± 1.39 | 0.115 |
| Creatinine (µmol/l) | 69.6 ± 13.7 | 75.2 ± 15.1 | <0.001 |
| Uric acid (µmol/l) | 316.9 ± 84.1 | 342.0 ± 90.7 | <0.001 |
| Potassium (mmol/l) | 3.71 ± 0.32 | 3.74 ± 0.34 | 0.246 |
| TC (mmol/l) | 4.09 ± 0.93 | 4.05 ± 0.93 | 0.587 |
| HDL-C (mmol/l) | 1.21 ± 0.33 | 1.11 ± 0.29 | <0.001 |
| LDL-C (mmol/l) | 2.53 ± 0.84 | 2.49 ± 0.80 | 0.522 |
| HBG (g/l) | 134.9 ± 13.9 | 142.1 ± 15.1 | <0.001 |
| WBC (10^9/L) | 6.16 ± 1.61 | 6.44 ± 1.59 | 0.023 |
| Neutrophil ratio | 0.58 ± 0.09 | 0.59 ± 0.09 | 0.020 |
| Lymphocyte ratio | 0.33 ± 0.08 | 0.31 ± 0.08 | 0.033 |
| Platelet count (10^9/L) | 227.2 ± 56.1 | 217.6 ± 54.3 | 0.022 |
| Diameters of coronary arteries | |||
| LCA (mm) | 4.15 ± 0.80 | 4.64 ± 0.82 | <0.001 |
| LAD (mm) | 3.21 ± 0.62 | 3.65 ± 0.65 | <0.001 |
| LCX (mm) | 2.85 ± 0.56 | 3.28 ± 0.66 | <0.001 |
| RAD (mm) | 3.16 ± 0.66 | 3.60 ± 0.71 | <0.001 |
| CTFC | |||
| LAD (frames) | 22 ± 4 | 46 ± 15 | <0.001 |
| LCX (frames) | 19 ± 5 | 35 ± 15 | <0.001 |
| RCA (frames) | 19 ± 5 | 37 ± 17 | <0.001 |
| ALT (U/l, Median [IQR]) | 16.9 (12.1-23.9) | 19.2 (14.3-28.1) | 0.001 |
| AST (U/l, Median [IQR]) | 16.2 (14.0-20.1) | 17.2 (14.7-20.9) | 0.037 |
| cTnT (ng/ml, Median [IQR]) | 0.006 (0.004-0.008) |
0.006 (0.004-0.008) |
0.222 |
| Glucose (mmol/l, Median [IQR]) | 5.34 (4.77-6.04) | 5.34 (4.86-5.98) | 0.889 |
| CK (U/L, Median [IQR]) | 72.2 (56.3-96.0) | 79.6 (60.4-110.5) | 0.060 |
| Myoglobin (U/L, Median [IQR]) | 22.8 (21.0-28.9) | 24.0 (21.0-31.3) | 0.182 |
| CK-MB (ng/ml, Median [IQR]) | 1.14 (0.83-1.57) | 1.23 (0.88-1.69) | 0.098 |
| NT-proBNP (pg/ml, Median [IQR]) | 50.20 (26.0-92.0) | 43.3 (24.1-93.4) | 0.267 |
| TG (mmol/l, Median [IQR]) | 1.32 (1.00-1.75) | 1.50 (1.07-2.08) | 0.002 |
| NLR (Median [IQR]) | 1.78 (1.33-2.37) | 1.87 (1.45-2.50) | 0.033 |
| SII (Median [IQR]) | 385 (285-525) | 389 (295-541) | 0.518 |